The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.
作者信息
Bassetti Matteo, Vena Antonio, Giacobbe Daniele Roberto
机构信息
Department of Health Sciences, University of Genoa, Genoa, Italy.
Clinica Malattie Infettive, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy.
出版信息
Eur J Clin Invest. 2020 Mar;50(3):e13209. doi: 10.1111/eci.13209. Epub 2020 Feb 5.
Abstract
摘要
相似文献
1
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.
Eur J Clin Invest. 2020 Mar;50(3):e13209. doi: 10.1111/eci.13209. Epub 2020 Feb 5.
2
A Novel Coronavirus (COVID-19) Outbreak: A Call for Action.
Chest. 2020 Apr;157(4):e99-e101. doi: 10.1016/j.chest.2020.02.014. Epub 2020 Feb 19.
3
The COVID-19 pandemic.
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S4-S6. doi: 10.5455/JPMA.02.
4
COVID-19: a new challenge for human beings.
Cell Mol Immunol. 2020 May;17(5):555-557. doi: 10.1038/s41423-020-0407-x. Epub 2020 Mar 31.
5
COVID-19 in Pediatrics: A Laboratory Perspective.
J Appl Lab Med. 2020 Jul 1;5(4):824-828. doi: 10.1093/jalm/jfaa065.
6
COVID-19: Main therapeutic options.
Tunis Med. 2020 Apr;98(4):299-303.
7
SnapShot: COVID-19.
Cell. 2020 May 14;181(4):954-954.e1. doi: 10.1016/j.cell.2020.04.013. Epub 2020 Apr 30.
8
Impact in the Fight Against COVID-19.
WMJ. 2020 Mar;119(1):69-70.
9
COVID-19: Time for precision epidemiology.
Exp Biol Med (Maywood). 2020 Apr;245(8):677-679. doi: 10.1177/1535370220919349. Epub 2020 Apr 17.
10
[Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)"].
Zhonghua Yi Xue Za Zhi. 2020 Mar 24;100(11):805-807. doi: 10.3760/cma.j.cn112137-20200205-00199.
引用本文的文献
1
Pharmacological Immunomodulation via Collagen-Polyvinylpyrrolidone or Pirfenidone Plays a Role in the Recovery of Patients with Severe COVID-19 Through Similar Mechanisms of Action Involving the JAK/STAT Signalling Pathway: A Pilot Study.
Adv Respir Med. 2025 Jul 18;93(4):24. doi: 10.3390/arm93040024.
2
Immunity and Coagulation in COVID-19.
Int J Mol Sci. 2024 Oct 19;25(20):11267. doi: 10.3390/ijms252011267.
3
Risk Factors Associated with Prolonged Nasopharyngeal Carriage of SARS-CoV-2 and Length of Stay among Patients Admitted to a COVID-19 Referral Center in Manila, Philippines.
Acta Med Philipp. 2023 Dec 18;57(12):66-72. doi: 10.47895/amp.vi0.5764. eCollection 2023.
4
Patient Characteristics and Clinical Outcomes During the 2020-2021 COVID-19 Wave: An Observational Study at a Tertiary Hospital in Saudi Arabia.
Cureus. 2024 Oct 9;16(10):e71119. doi: 10.7759/cureus.71119. eCollection 2024 Oct.
5
The Pandemics of Mass Destruction: A Comparative Analysis of HIV/AIDS and Coronavirus (COVID-19).
J Multidiscip Healthc. 2024 Mar 1;17:889-899. doi: 10.2147/JMDH.S440243. eCollection 2024.
6
Short-Term and Long-Term Impact of COVID-19 on Quality of Life and Psychological Outcomes in Saudi Arabia: A Comparative Cross-Sectional Study.
J Multidiscip Healthc. 2024 Feb 1;17:505-515. doi: 10.2147/JMDH.S449152. eCollection 2024.
7
Factors associated with long COVID syndrome in a Colombian cohort.
Front Med (Lausanne). 2023 Dec 22;10:1325616. doi: 10.3389/fmed.2023.1325616. eCollection 2023.
8
COVID-19 Vaccines and Assisted Reproductive Techniques: A Systematic Review.
J Pers Med. 2023 Aug 4;13(8):1232. doi: 10.3390/jpm13081232.
9
Knowledge, attitude, and practice toward COVID-19 transmission, prevention, and self-quarantine management among public servants in selected locations of the Sidama region, Southern Ethiopia: a multicenter cross-sectional study.
Front Public Health. 2023 Jun 27;11:1170317. doi: 10.3389/fpubh.2023.1170317. eCollection 2023.
10
Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease.
J Mol Struct. 2023 Jul 15;1284:135409. doi: 10.1016/j.molstruc.2023.135409. Epub 2023 Mar 23.
本文引用的文献
1
Why snakes probably aren't spreading the new China virus.
Nature. 2020 Jan 23. doi: 10.1038/d41586-020-00180-8.
2
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
3
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
Data sharing and outbreaks: best practice exemplified.
Lancet. 2020 Feb 15;395(10223):469-470. doi: 10.1016/S0140-6736(20)30184-7. Epub 2020 Jan 24.
6
A Novel Coronavirus from Patients with Pneumonia in China, 2019.
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
7
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.
N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.
8
Coronavirus Infections-More Than Just the Common Cold.
JAMA. 2020 Feb 25;323(8):707-708. doi: 10.1001/jama.2020.0757.
9
Cross-species transmission of the newly identified coronavirus 2019-nCoV.
J Med Virol. 2020 Apr;92(4):433-440. doi: 10.1002/jmv.25682.
10
A review of treatment modalities for Middle East Respiratory Syndrome.
J Antimicrob Chemother. 2016 Dec;71(12):3340-3350. doi: 10.1093/jac/dkw338. Epub 2016 Sep 1.
Zotero 插件